calcium acetate has been researched along with Cardiovascular Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aires, I; Amaral, T; Azevedo, A; Ferreira, A; Ferreira, C; Gil, C; Jorge, C; Laranjinha, I; Matias, PJ; Mendes, M; Navarro, D; Stuard, S | 1 |
| Floege, J | 1 |
| Hutchison, AJ; Mohammed, I | 1 |
| Assimon, MM; Mousa, S; Pai, AB; Shaker, O | 1 |
| Nolan, CR; Qunibi, WY | 1 |
| BAJUSZ, E; LEMIRE, Y; RENAUD, S; SELYE, H | 1 |
| Friedman, EA | 1 |
| Little, G; Otoo, A | 1 |
| Bellinghieri, G; Calò, LA; Monardo, P; Santoro, D; Savica, V | 1 |
| Blair, AT; Burke, SK; Cangiano, JL; Chasan-Taber, S; Dillon, MA; Fischer, D; Garrett, L; Ling, BN; Reed, J; Suki, WN; Zabaneh, R | 1 |
| Albu, AT; Dungaciu, M; El Esper, N; Fournier, A; Mornière, P; Oprisiu, R | 1 |
6 review(s) available for calcium acetate and Cardiovascular Diseases
| Article | Year |
|---|---|
Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: should we CARE-2 avoid them?
Topics: Acetates; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Humans; Phosphates; Polyamines; Randomized Controlled Trials as Topic; Renal Dialysis; Sevelamer | 2008 |
Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Topics: Acetates; Administration, Oral; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Magnesium; Nephrology; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
The effect of sevelamer hydrochloride and calcium-based phosphate binders on mortality in hemodialysis patients: a need for more research.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Clinical Trials as Topic; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Polyamines; Renal Dialysis; Sevelamer | 2010 |
Calcium salts in the treatment of hyperphosphatemia in hemodialysis patients.
Topics: Acetates; Calcium Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Drug Evaluation; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphate-Binding Proteins; Phosphates; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Treatment Outcome | 2003 |
Consequences and management of hyperphosphatemia in patients with renal insufficiency.
Topics: Acetates; Calcinosis; Calcium; Calcium Compounds; Cardiovascular Diseases; Diet; Humans; Hyperparathyroidism, Secondary; Phosphates; Renal Dialysis; Renal Insufficiency; Tomography, X-Ray Computed | 2005 |
Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer | 2006 |
1 trial(s) available for calcium acetate and Cardiovascular Diseases
| Article | Year |
|---|---|
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.
Topics: Acetates; Adult; Age Factors; Aged; Calcium; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Chronic Disease; Female; Humans; Kidney Diseases; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2007 |
4 other study(ies) available for calcium acetate and Cardiovascular Diseases
| Article | Year |
|---|---|
Calcium Acetate/Magnesium Carbonate and Cardiovascular Risk Factors in Chronic Hemodialysis Patients.
Topics: Acetates; Aged; Aged, 80 and over; Calcium Compounds; Cardiovascular Diseases; Humans; Magnesium; Middle Aged; Prospective Studies; Renal Dialysis; Risk Factors | 2016 |
Sensitization by dihydrotachysterol (DHT) and calcium acetate for the induction of cardiac lesions by various agents.
Topics: Acetates; Calcium; Calcium Compounds; Cardiovascular Diseases; Dihydrotachysterol; Humans; Myocarditis | 1959 |
Controversies in the management of hyperphosphatemia in patients with end-stage renal disease.
Topics: Acetates; Calcinosis; Calcium Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Conflict, Psychological; Disease Management; Humans; Kidney Failure, Chronic; Phosphates; Treatment Outcome; United States | 2006 |
The crossover comparative trial of calcium acetate versus sevelamer hydrochloride (Renagel) as phosphate binders in dialysis patients.
Topics: Acetates; Calcifediol; Calcinosis; Calcium; Calcium Compounds; Capsules; Cardiovascular Diseases; Cross-Over Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2000 |